Correlation Between Tscan Therapeutics and First Republic
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and First Republic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and First Republic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and First Republic Bank, you can compare the effects of market volatilities on Tscan Therapeutics and First Republic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of First Republic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and First Republic.
Diversification Opportunities for Tscan Therapeutics and First Republic
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Tscan and First is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and First Republic Bank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on First Republic Bank and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with First Republic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of First Republic Bank has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and First Republic go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and First Republic
Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 0.23 times more return on investment than First Republic. However, Tscan Therapeutics is 4.42 times less risky than First Republic. It trades about 0.06 of its potential returns per unit of risk. First Republic Bank is currently generating about -0.04 per unit of risk. If you would invest 210.00 in Tscan Therapeutics on August 29, 2024 and sell it today you would earn a total of 254.00 from holding Tscan Therapeutics or generate 120.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 31.45% |
| Values | Daily Returns |
Tscan Therapeutics vs. First Republic Bank
Performance |
| Timeline |
| Tscan Therapeutics |
| First Republic Bank |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Tscan Therapeutics and First Republic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and First Republic
The main advantage of trading using opposite Tscan Therapeutics and First Republic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, First Republic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in First Republic will offset losses from the drop in First Republic's long position.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
| First Republic vs. BorgWarner | First Republic vs. Rivian Automotive | First Republic vs. Aptiv PLC | First Republic vs. U Power Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |